Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR153191 plus methotrexate versus placebo and golimumab in rheumatoid arthritis
2010-021020-94Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Sep 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sarilumab in rheumatoid arthritis (RA) (3 arms), sponsored by Sanofi. Primary endpoint: ACR20 response. Started Sep 2010; status: terminated.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-021020-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021020-94.